Therapeutic targeting of escort proteins

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61P 31/12 (2006.01) C07K 16/18 (2006.01)

Patent

CA 2668773

The invention provides for inhibition of viral disease by the provision to a mammalian host of antibodies directed against an escort protein likeTsg101. These proteins appear on the surface of a cell, and thus can be bound by circulating antibodies thereto. By binding escort proteins on the cell surface, budding of viral particles is inhibited. The virus infects the initial cells, but cannot escape that cell to infect the body en masse.

La présente invention concerne l'inhibition de maladie virale par l'administration à un hôte de type mammifère d'anticorps dirigés contre une protéine d'escorte telle que la Tsg101. Ces protéines apparaissent sur la surface d'une cellule, et peuvent ainsi se lier à des anticorps en circulation. En liant les protéines d'escorte sur la surface cellulaire, le bourgeonnement de particules virales est inhibé. Le virus infecte les cellules initiales, mais ne peut pas s'échapper de la cellule pour infecter le corps en masse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic targeting of escort proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic targeting of escort proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic targeting of escort proteins will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1481946

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.